Profile
Dr (MD) Laura Kim
Charité - University Medicine Berlin, Germany
Presentation
11:20 CEST / Session: Treatment II: Clinical trials
Hyperbaric oxygen therapy (HBOT) trial in ME/CFS
Dr Laura Kim was previously acting as a physician and researcher at the Institute of Medical Immunology at Charité – University Medicine Berlin in Germany, where she was a member of Prof Carmen Scheibenbogen's research group on "Clinical Immunology and Immune Monitoring". In her previous role, she acted as the coordinator of several clinical trials implemented within the framework of the National Clinical Studies Group ME/CFS and Post-COVID Syndrom (NKSG) at Charité.